Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Javier Contreras, Sandra Hernández, Paulina Quezada, Albana Dassori, Consuelo Walss-Bass, Michael Escamilla & Henriette Raventos. (2010) Association of Serotonin Transporter Promoter Gene Polymorphism (5-HTTLPR) With Depression in Costa Rican Schizophrenic Patients. Journal of Neurogenetics 24:2, pages 83-89.
Read now
Read now
Jinger G. Hoop. (2008) Ethical Considerations in Psychiatric Genetics. Harvard Review of Psychiatry 16:6, pages 322-338.
Read now
Read now
Articles from other publishers (19)
Kuldeepak Sharma, Ankush Sundriyal, Aanchal Loshali, Mohit Agrawal, Chinnabonia Gopala Krishna & Yogendra Singh. 2023. How Synthetic Drugs Work. How Synthetic Drugs Work
255
273
.
Sada W. AbdulqaderIbrahim M. FaisalM. G. SaeedMarwan M. Merkhan. (2022) Fluvoxamine Suppressed Oxidative Stress associated with Tissue Erosion. Research Journal of Pharmacy and Technology, pages 819-824.
Crossref
Crossref
Xiaomin Wang, Ke Wang, Xiangmin Wu, Wenxiu Huang & Li Yang. (2022) Role of the cAMP–PKA–CREB–BDNF pathway in abnormal behaviours of serotonin transporter knockout mice. Behavioural Brain Research 419, pages 113681.
Crossref
Crossref
Philippe E. Nashar, Aidan A. Whitfield, Jiri Mikusek & Tristan A. Reekie. 2022. Oxytocin. Oxytocin
153
174
.
Joseph S. Lonstein. (2018) The dynamic serotonin system of the maternal brain. Archives of Women's Mental Health 22:2, pages 237-243.
Crossref
Crossref
Kristi Pettai, Lili Milani, Anu Tammiste, Urmo Võsa, Raivo Kolde, Triin Eller, David Nutt, Andres Metspalu & Eduard Maron. (2016) Whole-genome expression analysis reveals genes associated with treatment response to escitalopram in major depression. European Neuropsychopharmacology 26:9, pages 1475-1483.
Crossref
Crossref
Raúl Ventura-Junca & Luisa M. Herrera. (2014) Epigenetic alterations related to early-life stressful events. Acta Neuropsychiatrica 24:5, pages 255-265.
Crossref
Crossref
Edward C. Lauterbach. (2012) An extension of hypotheses regarding rapid-acting, treatment-refractory, and conventional antidepressant activity of dextromethorphan and dextrorphan. Medical Hypotheses 78:6, pages 693-702.
Crossref
Crossref
Eric J. Lenze, Rose C. Mantella, Peichang Shi, Alison M. Goate, Petra Nowotny, Meryl A. Butters, Carmen Andreescu, Paul A. Thompson & Bruce L. Rollman. (2011) Elevated Cortisol in Older Adults With Generalized Anxiety Disorder Is Reduced by Treatment: A Placebo-Controlled Evaluation of Escitalopram. The American Journal of Geriatric Psychiatry 19:5, pages 482-490.
Crossref
Crossref
Jerson Laks & Eliasz Engelhardt. (2010) Peculiarities of Geriatric Psychiatry: A Focus on Aging and Depression. CNS Neuroscience & Therapeutics 16:6, pages 374-379.
Crossref
Crossref
Olga O. Yevtushenko & Gavin P. Reynolds. 2010. Handbook of the Behavioral Neurobiology of Serotonin. Handbook of the Behavioral Neurobiology of Serotonin
791
806
.
George M. Brenner & Craig W. Stevens. 2010. Pharmacology. Pharmacology
235
252
.
George S. Alexopoulos, Christopher F. Murphy, Faith M. Gunning-Dixon, Charles E. Glatt, Vassilios Latoussakis, Robert E. KellyJr.Jr., Dora Kanellopoulos, Sibel Klimstra, Kelvin O. Lim, Robert C. Young & Matthew J. Hoptman. (2009) Serotonin transporter polymorphisms, microstructural white matter abnormalities and remission of geriatric depression. Journal of Affective Disorders 119:1-3, pages 132-141.
Crossref
Crossref
Laura Mandelli, Marianna Mazza, Giovanni Martinotti, Marco Di Nicola, Daniela Tavian, Elisa Colombo, Sara Missaglia, Diana De Ronchi, Roberto Colombo, Luigi Janiri & Alessandro Serretti. (2009) Harm avoidance moderates the influence of serotonin transporter gene variants on treatment outcome in bipolar patients. Journal of Affective Disorders 119:1-3, pages 205-209.
Crossref
Crossref
Amélie Lothe, Claudette Boni, Nicolas Costes, Philip Gorwood, Sandrine Bouvard, Didier Le Bars, Franck Lavenne & Philippe Ryvlin. (2009) Association between triallelic polymorphism of the serotonin transporter and [18F]MPPF binding potential at 5-HT1A receptors in healthy subjects. NeuroImage 47:2, pages 482-492.
Crossref
Crossref
B. M. Anderson, N. C. Schnetz-Boutaud, J. Bartlett, A. M. Wotawa, H. H. Wright, R. K. Abramson, M. L. Cuccaro, J. R. Gilbert, M. A. Pericak-Vance & J. L. Haines. (2009) Examination of association of genes in the serotonin system to autism. neurogenetics 10:3, pages 209-216.
Crossref
Crossref
Terry E. Goldberg, Roman Kotov, Annette T. Lee, Peter K. Gregersen, Todd Lencz, Evelyn Bromet & Anil K. Malhotra. (2009) The serotonin transporter gene and disease modification in psychosis: Evidence for systematic differences in allelic directionality at the 5-HTTLPR locus. Schizophrenia Research 111:1-3, pages 103-108.
Crossref
Crossref
Terence Y.C. Pang, Xin Du, Michelle S. Zajac, Monique L. Howard & Anthony J. Hannan. (2009) Altered serotonin receptor expression is associated with depression-related behavior in the R6/1 transgenic mouse model of Huntington's disease. Human Molecular Genetics 18:4, pages 753-766.
Crossref
Crossref
J. Contreras, L. Hare, B. Camarena, D. Glahn, A. Dassori, R. Medina, S. Contreras, M. Ramirez, R. Armas, R. Munoz, R. Mendoza, H. Raventos, A. Ontiveros, H. Nicolini, R. Palmer & M. Escamilla. (2009) The serotonin transporter 5-HTTPR polymorphism is associated with current and lifetime depression in persons with chronic psychotic disorders. Acta Psychiatrica Scandinavica 119:2, pages 117-127.
Crossref
Crossref